Home
About
Overview
Sharing Data
ORCID
Help
History (32)
Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation.
Concomitant Traumatic Brain Injury Delays Surgery in Patients With Traumatic Spinal Cord Injury.
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?
FMRI OF NEURAL CIRCUITS IN EYEBLINK CONDITIONING
Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
See All 32 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
Myeloid cell heterogeneity in lung cancer: implication for immunotherapy. Cancer Immunol Immunother. 2021 Sep; 70(9):2429-2438.
View in:
PubMed
subject areas
Animals
Biomarkers
Biomarkers, Tumor
Disease Management
Disease Susceptibility
Gene Expression
Humans
Immunohistochemistry
Immunotherapy
Lung Neoplasms
Molecular Targeted Therapy
Myeloid Cells
authors with profiles
Marina Chiara Garassino